- Breakthrough on Huntington’s disease
- Research offers promising new approach to treatment of lung cancer
- Acne treatment: Natural substance-based formula is more effective than artificial compounds
- Drugs found to both prevent and treat Alzheimer’s disease in mice
- Poliovirus vaccine trial shows early promise for recurrent glioblastoma
- Mayo Clinic: How gold nanoparticles can help fight ovarian cancer
- Resistance to last-line antibiotic makes bacteria resistant to immune system
- Study suggests new source of kidneys for transplant
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington’s disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
“We are the first to show that it is possible to prevent the depression symptoms of Huntington’s disease by deactivating the diseased protein in nerve cell populations in the hypothalamus in the brain. This is hugely exciting and bears out our previous hypotheses”, explains Åsa Petersén, Associate Professor of Neuroscience at Lund University.
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors.
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer’s Disease in mice.
The drugs, known as “TSPO ligands,” are currently used for certain types of neuroimaging.
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective against ovarian cancer cells. The discovery is detailed in the current online issue of the Journal of Biological Chemistry.